NYSE:PFE

Pfizer Inc (PFE)

25.71
+0.37 (1.46%)
as of Jun 4, 2026, 6:38:50 pm Market Open.
579 watching
0
Investor Insights
star iconJun 4, 2026, 12:00 am

This summary was created by AI, based on 31 opinions in the last 12 months.

Pfizer Inc (PFE) is facing significant challenges stemming from a patent cliff, leading to concerns about its drug pipeline and growth prospects in the coming years. Analysts emphasize the company's attractive dividend yield, which hovers around 6-7%, making it appealing for income-focused investors. However, many reviews suggest that the lack of earnings momentum and the need for new blockbuster drugs remain critical issues. Despite a robust pipeline and recent acquisitions, the absence of immediate catalysts for growth has left investors cautious. Overall, while Pfizer provides a decent dividend, its future performance hinges on successful drug development and navigating market sentiment around healthcare reforms.

consensus icon
Consensus
Hold
valuation icon
Valuation
Undervalued
review icon
Similar
NVO
HOLD
Questioner: "Why is it stuck in a $30/31 range?" Response: "Likes at this price. Their drugs and pipeline are good. Has a lot of cash."
BUY
A favourite drug stock in their funds. Earnings growth should be 15% over the next several years. Dividend yield is decent. Has a very good pipeline of drugs.
TOP PICK
Just completed a good merger with Pharmacia. Good pipeline.
TOP PICK
Just got approval on new products and should move up.
DON'T BUY
More expensive in the drug sector. Merk is a better buy.
BUY
Pretty good value. The merger will allow some cost cutting. A good price.
BUY
HOLD
Well run and strong management. Has grown so big that future growth is difficult.
BUY
Not doing much, but a good stock to own.
BUY
Likes the pharmaceutical group. Acquisition of Pharmacia is positive.
BUY
Likes. Great value.
HOLD
Good merger made. Good company.
BUY
Positive on the drug industry.
BUY
Strong pipeline. Republican win is good for pharmaceuticals.
BUY
Should start to see a rise.
Showing 781 to 795 of 883 entries